Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
434 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Stomach Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
Conditions: Colorectal Cancer;   Stomach Disease
Interventions: Other: FIT(Eiken OC-Sensor) Two-day sampling;   Other: FIT(Eiken OC-Sensor) One-year interval;   Other: FIT(Eiken OC-Sensor) One-day sampling;   Other: FIT(Eiken OC-Sensor) Two-year interval;   Other: HpSA (Firstep Helicobacter pylori Antigen Rapid Test)
2 Not yet recruiting A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy
Condition: NSAID-induced Gastropathy
Interventions: Drug: bismuth tripotassium dicitrate;   Drug: pantoprazole
3 Recruiting Gastric Preparation of Magnetic-controlled Capsule Endoscopy
Condition: Stomach Diseases
Interventions: Other: clear water;   Drug: simethicone;   Drug: simethicone combined with pronase
4 Recruiting Conventional Direct Laryngoscopy Vs. Video Laryngoscopy With The C-MAC For Pyloromyotomy
Conditions: Pyloric Stenosis;   Intubation, Pediatric
Intervention: Device: Video Laryngoscopy
5 Recruiting The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents
Condition: Malignant Gastric Outlet Obstruction
Interventions: Device: Winged stent (partially covered);   Device: Winged stent (uncovered)
6 Not yet recruiting A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
Condition: Gastritis
Interventions: Device: The results of clarithromycin susceptibility test of H. pylori isolates;   Device: Computer generated random number, randomly assigned into groups;   Device: The result of 13C-urea breath test of patient in 7days/10days/14days treatment groups
7 Not yet recruiting Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Condition: Gastritis Associated With Helicobacter Pylori
Interventions: Drug: vonoprazan 20 mg bid;   Drug: Amoxicillin 500 mg tid;   Drug: Amoxicillin 750 mg bid;   Drug: Clarithromycin 200 mg bid;   Drug: Metronidazole 250 mg bid
8 Recruiting A Multi-center Study for Eradication of Refractory Helicobacter Pylori
Condition: Gastritis
Interventions: Device: The result of H pylori culture based on gram staining and enzyme activity testing;   Device: The result of 13C-urea breath test after treatment based on the selection of clarithromycin, levofloxacin, metronidazole, amoxicillin,tetracycline,furazolidone and the dose of esomeprazole;   Device: The result of Amoxicillin resistance in vitro based on antibiotic susceptibility testing
9 Recruiting Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
Condition: Helicobacter-associated Gastritis
Interventions: Drug: Nitazoxanide;   Drug: Metronidazole(MTZ);   Drug: Omeprazole;   Drug: Clarithromycin;   Drug: Levofloxacin;   Drug: Doxicycline
10 Recruiting i-Scan for the Detection of Helicobacter Pylori
Condition: Gastritis
Interventions: Device: i-scan;   Device: narrow band imaging
11 Recruiting Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Condition: Gastritis
Interventions: Drug: GC6101A 37.5mg;   Drug: GC6101A 75mg;   Drug: GC6101A 150mg;   Drug: Placebo
12 Recruiting Domperidone for Refractory Gastrointestinal Disorders
Condition: Gastroparesis
Intervention: Drug: Domperidone
13 Recruiting UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
Condition: Peptic Ulcer
Interventions: Procedure: endoscopic adhesive powder;   Drug: epinephrine;   Device: Endoscopic Wound Dressing (Next Biomedical)
14 Not yet recruiting The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Condition: Chronic Atrophic Gastritis
Interventions: Drug: Talcid®;   Drug: Chinese medicine prescription;   Drug: Placebo;   Drug: Compound Azimtamide Entieric-coated Tablets
15 Not yet recruiting Linked Color Imaging/Magnifying Blue Laser Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy
Conditions: Gastritis;   Helicobacter Pylori Associated Gastritis;   Atrophic Gastritis
Intervention: Device: Digital chromoendoscopy and magnification
16 Not yet recruiting The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Condition: Peptic Ulcer
Interventions: Drug: Ilaprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole
17 Not yet recruiting Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Condition: Acute and Chronic Gastric Inflammation Patients
Interventions: Drug: DW-3101_150mg;   Drug: DW-3101_300mg;   Drug: DW-3101_600mg;   Drug: Placebo
18 Recruiting Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Conditions: Gastroenteritis;   Gastritis
Intervention: Drug: RHB-102
19 Recruiting Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
Condition: Atrophic Gastritis
Intervention: Drug: pepsinogen and gastrin
20 Not yet recruiting Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Condition: Gastroparesis
Interventions: Drug: VLY-686;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.